For the most current FDA policy on compounded medications and the status of the tirzepatide shortage, consult the FDA drug shortage database and the official FDA guidance
When to speak to your GP or oncologist Contact your GP, prescriber, or oncology team if you experience: Any new lumps, changes in the affected or unaffected breast, or new symptoms that prompt concern about recurrence Persistent nausea or vomiting that stops you from keeping fluids down Rapid or significant weight loss beyond whats expected Signs of dehydration (dark urine, dizziness, reduced urination) New fatigue that feels different from your post-treatment fatigue Worsening joint pain or new bone pain Increasing anxiety, low mood, or fear of recurrence thats affecting daily life Any difficulty attending cancer follow-up appointments because of side effects Dont delay routine cancer surveillance because of Wegovy
In the SURPASS trials, tirzepatide achieved greater reductions in body weight, glycemia, and lipids compared to GLP-1RAs alone (171)
Adequate zinc intake is directly relevant: zinc is essential for testosterone synthesis, and deficiency is associated with reduced testosterone levels
Are peptide capsules as reliable for research as injectables
Contrary to Defendants assertions, they are not entitled to a blanket ruling on preemption that the warnings in their GLP-1RA labels were adequate, and Plaintiffs claims do not arise merely from nausea, vomiting, or constipation
